📊 VIX Forecasting Summary
Asset: CBOE Volatility Index (VIX)
Forecast Type: Multi-level structural roadmap (Wave + Distribution Model)
Next Distribution Level:
Level 1: $23.09
Level 2: $27.97
Level 3: $50.51
Level 4: $63.95
🔹 Forecast Model Highlights:
Structured in 3 Phases:
• Stage 1: Accumulation Phase
• Stage 2: Advance Phase
• Stage 3: Distribution Phase
Wave Construction:
• Precise multi-wave pattern analysis incorporating nested wave symmetry and pivot validation.
• Strategic pullbacks identified as necessary retracement points before next breakout.
• Clear support at $14.43 and $14.94 identified as baseline cyclical lows.
📉 Drop Zones Mapped (Support Levels):
• $19.55 (initial retracement warning)
• $18.21 (critical interim support)
• $14.94 and $14.43 (cyclical reset base)
• Primary drop if mid support failed, $11.70 , $12.25
Asset: CBOE Volatility Index (VIX)
Forecast Type: Multi-level structural roadmap (Wave + Distribution Model)
Next Distribution Level:
Level 1: $23.09
Level 2: $27.97
Level 3: $50.51
Level 4: $63.95
🔹 Forecast Model Highlights:
Structured in 3 Phases:
• Stage 1: Accumulation Phase
• Stage 2: Advance Phase
• Stage 3: Distribution Phase
Wave Construction:
• Precise multi-wave pattern analysis incorporating nested wave symmetry and pivot validation.
• Strategic pullbacks identified as necessary retracement points before next breakout.
• Clear support at $14.43 and $14.94 identified as baseline cyclical lows.
📉 Drop Zones Mapped (Support Levels):
• $19.55 (initial retracement warning)
• $18.21 (critical interim support)
• $14.94 and $14.43 (cyclical reset base)
• Primary drop if mid support failed, $11.70 , $12.25
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
[email protected]
For institutional review, independent verification, or strategic collaboration:
[email protected]
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Institutional Note:
For institutional review, independent verification, or strategic collaboration:
[email protected]
For institutional review, independent verification, or strategic collaboration:
[email protected]
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.